Insider Trading & Ownership - King Rachel K.

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for King Rachel K.
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2021-05-19
Purchase
2021-05-21
5:06 pm
NOVAVAX INCKing Rachel K.
Director
700$139.64$97,7485,000
(Indirect
Direct)
View
2020-12-28
Sale
2020-12-30
4:00 pm
GLYCOMIMETICS INCGLYCKing Rachel K.
President, CEO
84,176$3.91$329,128531,206
(Indirect
Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-05-01
Option Award
2024-05-01
4:27 pm
N/A
2034-04-30
GLYCOMIMETICS INCGLYCKing Rachel K.
Director
40,000$040,000
(Direct)
View
2024-03-29
Option Award
2024-04-02
4:05 pm
N/A
N/A
GLYCOMIMETICS INCGLYCKing Rachel K.
Director
3,334$3659,095
(Direct)
View
2023-12-29
Option Award
2024-01-02
4:05 pm
N/A
N/A
GLYCOMIMETICS INCGLYCKing Rachel K.
Director
4,238$2.36657,502
(Direct)
View
2023-09-30
Option Award
2023-10-03
4:05 pm
N/A
N/A
GLYCOMIMETICS INCGLYCKing Rachel K.
Director
6,667$1.5653,264
(Direct)
View
2023-06-10
Exercise
2023-06-13
4:46 pm
N/A
N/A
NOVAVAX INCKing Rachel K.
Director
3,100$026,630
(Direct)
View
2023-06-12
Option Award
2023-06-13
4:46 pm
2024-06-12
2033-06-12
NOVAVAX INCKing Rachel K.
Director
14,380$026,630
(Direct)
View
2023-05-19
Option Award
2023-05-22
4:27 pm
N/A
2033-05-18
GLYCOMIMETICS INCGLYCKing Rachel K.
Director
35,000$035,000
(Direct)
View
2022-02-15
Ownership
2023-02-06
4:13 pm
N/A
N/A
GLYCOMIMETICS INCGLYCKing Rachel K.
Director
19,141$0646,597
(Direct)
View

Ownership
2023-02-06
4:13 pm
N/A
N/A
GLYCOMIMETICS INCGLYCKing Rachel K.
Director
0$0646,597
(Indirect)
View
2022-06-17
Exercise
2022-06-21
8:46 pm
N/A
N/A
NOVAVAX INCKing Rachel K.
Director
700$09,150
(Direct)
View
2022-06-10
Option Award
2022-06-14
5:08 pm
2023-06-10
2032-06-10
NOVAVAX INCKing Rachel K.
Director
7,700$07,700
(Direct)
View
2022-05-18
Option Award
2022-05-20
4:16 pm
N/A
2032-05-17
GLYCOMIMETICS INCGLYCKing Rachel K.
Director
21,000$021,000
(Direct)
View
2021-06-25
Exercise(A)
2021-08-20
5:29 pm
N/A
N/A
NOVAVAX INCKing Rachel K.
Director
3,450$09,700
(Direct)
View
2021-06-25
Exercise
2021-06-29
5:14 pm
N/A
N/A
NOVAVAX INCKing Rachel K.
Director
6,900$011,900
(Direct)
View
2021-06-17
Option Award
2021-06-22
5:18 pm
2022-06-17
2031-06-17
NOVAVAX INCKing Rachel K.
Director
2,000$02,000
(Direct)
View
2021-01-20
Option Award
2021-01-22
4:00 pm
N/A
2031-01-19
GLYCOMIMETICS INCGLYCKing Rachel K.
President, CEO
288,750$0819,956
(Direct)
View
2020-12-28
Exercise
2020-12-30
4:00 pm
N/A
2021-01-04
GLYCOMIMETICS INCGLYCKing Rachel K.
President, CEO
130,821$0531,206
(Direct)
View
2020-12-28
Exercise
2020-12-30
4:00 pm
N/A
N/A
GLYCOMIMETICS INCGLYCKing Rachel K.
President, CEO
130,821$1.12531,206
(Direct)
View
2020-06-25
Option Award
2020-06-26
9:18 pm
2021-06-25
2030-06-25
NOVAVAX INCKing Rachel K.
Director
10,350$010,350
(Direct)
View
2020-01-22
Option Award
2020-01-24
4:14 pm
N/A
2030-01-21
GLYCOMIMETICS INCGLYCKing Rachel K.
President, CEO
349,000$0349,000
(Direct)
View
2019-12-12
Option Award
2019-12-16
5:00 pm
2020-12-12
2029-12-12
NOVAVAX INCKing Rachel K.
Director
18,000$018,000
(Direct)
View
2019-08-06
Exercise
2019-08-07
4:29 pm
N/A
2021-01-04
GLYCOMIMETICS INCGLYCKing Rachel K.
President, CEO
166,759$0615,382
(Direct)
View
2019-08-06
Exercise
2019-08-07
4:29 pm
N/A
N/A
GLYCOMIMETICS INCGLYCKing Rachel K.
President, CEO
166,759$1.12615,382
(Direct)
View
(A) Indicate amendment filing.